Enterococcal bacteraemia "Silent but deadly": a population-based cohort study.
The high mortality rate of patients with enterococcal infections has been shown to be associated with the severity of underlying comorbidities. to characterise the epidemiology, clinical characteristics, outcomes and predictors of mortality in patients with enterococcal bacteraemia. a retrospective cohort study of all enterococcal bacteraemia episodes in the Barwon region between January 2010 - March 2017. We assessed the epidemiology, clinical characteristics, outcomes and predictors of mortality using descriptive statistics and simple and multiple logistic regression analyses. The incidence of enterococcal bacteraemia was 19.9/100 000 person-years. Males comprised 68.4% and the median age was 71 years. Common comorbidities were gastrointestinal tract disease, urological disease, malignancies and cardiovascular disease. Infective endocarditis was observed in 15% of patients and 1 of 27 also had colorectal cancer. Twelve patients referred for colonoscopy revealed previously undiagnosed colorectal neoplasia (CRN) in 75% of these cases. 30-day and 1-year mortality rates were 11.7% and 40.2% respectively. Sixty-nine cases with vancomycin resistant Enterococcus occurred. Multiple logistic regression suggested that the presence of underlying urological malignancy (adjusted OR=3.57, 95% CI= (1.10, 11.65), p=0.035) and colorectal cancer (adjusted OR=4.47, 95% CI= (1.36, 14.66), p=0.014) were significant predictors of 1-year mortality. Microbiological cure was inversely associated with 30-day mortality. The presence of underlying urological and colorectal malignancy were predictors of 1-year mortality. We identified the importance of evaluating patients with E. faecalis bacteremia for underlying CRN. Routine colonoscopy is recommended in patients with Enterococcus faecalis bacteraemia or IE with an unclear source of infection. This article is protected by copyright. All rights reserved.